BriaCell Therapeutics Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/28/2024 | Q4 2024 | -$0.07 | $0 | |||
| 06/14/2024 | Q3 2024 | $102.89 | $0 | |||
| 03/18/2024 | Q2 2024 | -$0.71 | $0 | |||
| 12/14/2023 | Q1 2024 | $0.90 | $0 | |||
| 10/25/2023 | Q4 2023 | -$0.16 | $0 | |||
| 06/14/2023 | Q3 2023 | -$0.32 | $0 | |||
| 03/15/2023 | Q2 2023 | -$0.77 | $0 | |||
| 12/14/2022 | Q1 2023 | -$0.32 | $0 | |||
| 10/27/2022 | Q4 2022 | -$1.24 | $0 | |||
| 06/13/2022 | Q3 2022 | $0.00 | $0 | |||
| 06/13/2022 | Q2 2022 | $0.00 | $0 | |||
| 10/29/2021 | Q1 2022 | $58.47 | $0 | |||
| 10/29/2021 | Q4 2021 | $0.15 | $0 | |||
| 04/01/2021 | Q3 2021 | $0.00 | $0 | |||
| 04/01/2021 | Q2 2021 | $0.00 | $0 | |||
| 10/31/2020 | Q1 2021 | $0.00 | $0 | |||
| 07/31/2020 | Q4 2020 | $0.00 | $0 | |||
| 04/30/2020 | Q3 2020 | $0.00 | $0 | |||
| 01/31/2020 | Q2 2020 | $0.00 | $0 | |||
| 10/31/2019 | Q1 2020 | $0.00 | $0 |
BriaCell Therapeutics Corp. Earnings: Frequently Asked Questions
-
When is BriaCell Therapeutics Corp.'s earnings date?
BriaCell Therapeutics Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Saturday, April 29th, 2023 based off last year's report dates.
-
How can I listen to BriaCell Therapeutics Corp.'s earnings conference call?
The conference call for BriaCell Therapeutics Corp.'s latest earnings report can be listened to online.
-
How can I read BriaCell Therapeutics Corp.'s conference call transcript?
The conference call transcript for BriaCell Therapeutics Corp.'s latest earnings report can be read online.
-
How much profit does BriaCell Therapeutics Corp. generate each year?
BriaCell Therapeutics Corp. (:BCTXW) has a recorded net income of $0. BriaCell Therapeutics Corp. has generated $-0.29 earnings per share over the last four quarters.
-
What is BriaCell Therapeutics Corp.'s price-to-earnings ratio?
BriaCell Therapeutics Corp. (:BCTXW) has a price-to-earnings ratio of -1.06 and price/earnings-to-growth ratio is 0.8.
